Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Kidney Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Genitourinary System Neoplasm
Urinary System Neoplasm
Kidney and Ureter Neoplasm
Kidney Neoplasm

Subtype

Kidney Neoplasm

CI-CAN-00002988Explore in graph →

Non-malignant481 active trials17 approved drugs80 evidence items

NCIt: C3150
MeSH: D007680

Overview
Statistics
Survival
Genomics25
Variants & evidence80
Drugs9
Trials2320
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (93)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 76–93 of 93 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
· BMC Cancer · 2005 · PMID 15932632 · validated civic_curation pubmed
VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
· Oncogene · 2001 · PMID 11536052 · validated civic_curation pubmed
Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers.
· Int J Cancer · 1995 · PMID 7591282 · validated civic_curation pubmed
Mutations of the VHL tumour suppressor gene in renal carcinoma.
· Nat Genet · 1994 · PMID 7915601 · validated civic_curation pubmed
[A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dubé syndrome treated with molecular-targeting agents].
· Hinyokika Kiyo · 2013 · PMID 23995526 · validated civic_curation pubmed
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.
· Nat Med · 2006 · PMID 16341243 · validated civic_curation pubmed
PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.
· Anticancer Res · 2013 · PMID 23898052 · validated civic_curation

Showing 76–93 of 93 publications

← Previous
1
2
3
4
Next →

Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

· Cancer · 2012 · PMID 22252991 · validated civic_curation pubmed

Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinoma.

· Cancer Res · 2014 · PMID 24253377 · validated civic_curation pubmed

Miao et al. Science 2019

· 2019 · PMID 29301960 · validated cbioportal_study pubmed

Choueiri et al. Clin Cancer Res. 2016

· 2016 · PMID 27169994 · validated cbioportal_study pubmed

Gerlinger et al. Nat Genet 2014

· 2014 · PMID 24487277 · validated cbioportal_study pubmed

Vasudev, Neeraj S. et al. Clinical Cancer Research, 2023

· 2023 · PMID 36815791 · validated cbioportal_study pubmed

TCGA, Cancer Cell 2014

· 2014 · PMID 25155756 · validated cbioportal_study pubmed

Guo et al. Nat Genet 2012

· 2012 · PMID 22138691 · validated cbioportal_study pubmed

Durinck et al. Nat Genet 2014

· 2014 · PMID 25401301 · validated cbioportal_study pubmed

McDermott et al. Nat Med 2018

· 2018 · PMID 29867230 · validated cbioportal_study pubmed

Chen et al. Nat Commun 2016

· 2016 · PMID 27713405 · validated cbioportal_study pubmed